IFNA2 and neoplasm: Recently, Professor Yang-Xin Fu and team engineered a receptor-masked IFNα-2b prodrug (hProIFNα2b-Fc; ProIFN) in which components are connected by a linker that can be cleaved by tumor-related proteases (Figure 6B).